Literature DB >> 361578

Immunological relationship of different preparations of coliform enterotoxins.

F A Klipstein, R F Engert.   

Abstract

Antisera raised in rabbits to ultrafiltrate toxin preparations containing either the heat-labile (LT) toxin form obtained from whole cell lysates or broth filtrates or the heat-stable (ST) toxin form prepared from broth filtrates from nontoxigenic and toxigenic strains of Escherichia coli and Klebsiella were examined for their ability to neutralize the secretory effect on water transport of these toxins in the rat jejunum as determined by the in vivo marker perfusion technique. Antisera to the heat-labile toxin derived from whole cell lysate preparations from nontoxigenic strains had no neutralizing effect. Antisera to both types of LT preparation from both toxigenic strains neutralized, with several exceptions, all of the homologous and heterologous LT toxins as well as a heat-labile toxin preparation derived from sequential ultrafiltration of cell-free whole cell lysates which had a defined molecular weight of between 30,000 and 100,000. These antisera also neutralized homologous and heterologous ST preparations obtained from broth filtrates, but they had no neutralizing effect on low-molecular-weight, ST toxin material obtained during the sequential ultrafiltration of cell lysates. Antisera to ST prepared from broth filtrates had no neutralizing capacity against either LT or ST toxin preparations. These observations (i) indicate that the immunological relationship of E. coli and Klebsiella LT and ST toxins extends to antisera raised against LT prepared by several different methods, (ii) raise the possibility that, based on the response to antisera to LT, there may be several immunologically heterogeneous forms of low-molecular-weight ST toxin, and (c) confirm the lack of immunogenicity of ST.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 361578      PMCID: PMC422064          DOI: 10.1128/iai.21.3.771-778.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Purification and properties of Klebsiella pneumoniae heat-stable enterotoxin.

Authors:  F A Klipstein; R F Engert
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

2.  Relative enterotoxigenicity of coliform bacteria.

Authors:  F A Klipstein; R F Engert; H B Short
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

3.  Enterotoxigenic Escherichia coli and Reovirus-like agent in rural Bangladesh.

Authors:  R W Ryder; D A Sack; A Z Kapikian; J C McLaughlin; J Chakraborty; A S Mizanur Rahman; M H Merson; J G Wells
Journal:  Lancet       Date:  1976-03-27       Impact factor: 79.321

4.  Toxigenic bacterial diarrhea: nursery outbreak involving multiple bacterial strains.

Authors:  R L Guerrant; M D Dickens; R P Wenzel; A Z Kapikian
Journal:  J Pediatr       Date:  1976-12       Impact factor: 4.406

5.  Partial purification and characterization of a heat-labile enterotoxin of Escherichia coli.

Authors:  I Schenkein; R F Green; D S Santos; W K Maas
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

6.  Infantile diarrhea produced by heat-stable enterotoxigenic Escherichia coli.

Authors:  R W Ryder; I K Wachsmuth; A E Buxton; D G Evans; H L DuPont; E Mason; F F Barrett
Journal:  N Engl J Med       Date:  1976-10-14       Impact factor: 91.245

7.  Isolation and properties of heat-labile enterotoxin(s) from enterotoxigenic Escherichia coli.

Authors:  R A Finkelstein; M K LaRue; D W Johnston; M L Vasil; G J Cho; J R Jones
Journal:  J Infect Dis       Date:  1976-03       Impact factor: 5.226

8.  Immunological interrelationships between cholera toxin and the heat-labile and heat-stable enterotoxins of coliform bacteria.

Authors:  F A Klipstein; R F Engert
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

9.  Protection against challenge with Escherichia coli heat-labile enterotoxin by immunization of rats with cholera toxin/toxoid.

Authors:  N F Pierce
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

10.  Antigenic similarity of heat-labile enterotoxins from diverse strains of Escherichia coli.

Authors:  R B Sack; J L Froehlich
Journal:  J Clin Microbiol       Date:  1977-06       Impact factor: 5.948

View more
  7 in total

1.  Influence of route of administration on immediate and extended protection in rats immunized with Escherichia coli heart-labile enterotoxin.

Authors:  F A Klipstein; R F Engert
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

2.  Molecular homogeneity of heat-stable enterotoxins produced by bovine enterotoxigenic Escherichia coli.

Authors:  A M Saeed; N S Magnuson; N Sriranganathan; D Burger; W Cosand
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

3.  Protective effect of active immunization with purified Escherichia coli heat-labile enterotoxin in rats.

Authors:  F A Klipstein; R F Engert
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

4.  Comparison of enterotoxic activities of heat-stable enterotoxins from class 1 and class 2 Escherichia coli of swine origin.

Authors:  S C Whipp; H W Moon; R A Argenzio
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

5.  Purification and characterization of heat-stable enterotoxin from bovine enterotoxigenic Escherichia coli.

Authors:  A M Saeed; N Sriranganathan; W Cosand; D Burger
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

6.  Synthesis of plasmid-coded heat-labile enterotoxin in wild-type and hypertoxinogenic strains of Escherichia coli and in other genera of Enterobacteriaceae.

Authors:  R J Neill; E M Twiddy; R K Holmes
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

7.  Protective effect of immunization with heat-labile enterotoxin in gnotobiotic rats monocontaminated with enterotoxigenic Escherichia coli.

Authors:  F A Klipstein; R F Engert; H B Short
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.